Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...

Over the past six months, Zimmer Biomet’s stock price fell to $99.17. Shareholders have lost 12% of their capital, which is disappointing considering the S&P 500 has climbed by 24.7%. This might have ...

Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best ...

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $98.85 1.92% Open 98.935 Day High 101.083 52 Week High 133.6 52 Week ...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes ...

Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...

Investors interested in Medical - Products stocks are likely familiar with Zimmer Biomet (ZBH) and Medtronic (MDT). But which of these two stocks is more attractive to value investors? We'll need to ...

Zimmer Biomet Holdings, Inc. (ZBH) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...

Zimmer Biomet (NYSE: ZBH) announced yesterday that it launched two new solutions for complex foot and ankle trauma.